1. Home
  2. IPI vs RGNX Comparison

IPI vs RGNX Comparison

Compare IPI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPI
  • RGNX
  • Stock Information
  • Founded
  • IPI 2000
  • RGNX 2008
  • Country
  • IPI United States
  • RGNX United States
  • Employees
  • IPI N/A
  • RGNX N/A
  • Industry
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IPI Industrials
  • RGNX Health Care
  • Exchange
  • IPI Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • IPI 470.9M
  • RGNX 451.1M
  • IPO Year
  • IPI 2008
  • RGNX 2015
  • Fundamental
  • Price
  • IPI $28.64
  • RGNX $9.26
  • Analyst Decision
  • IPI Strong Sell
  • RGNX Strong Buy
  • Analyst Count
  • IPI 1
  • RGNX 8
  • Target Price
  • IPI $23.00
  • RGNX $28.50
  • AVG Volume (30 Days)
  • IPI 167.0K
  • RGNX 528.4K
  • Earning Date
  • IPI 11-03-2025
  • RGNX 11-05-2025
  • Dividend Yield
  • IPI N/A
  • RGNX N/A
  • EPS Growth
  • IPI N/A
  • RGNX N/A
  • EPS
  • IPI N/A
  • RGNX N/A
  • Revenue
  • IPI $225,166,000.00
  • RGNX $155,782,000.00
  • Revenue This Year
  • IPI $10.01
  • RGNX $203.27
  • Revenue Next Year
  • IPI $1.35
  • RGNX $0.58
  • P/E Ratio
  • IPI N/A
  • RGNX N/A
  • Revenue Growth
  • IPI 10.53
  • RGNX 74.95
  • 52 Week Low
  • IPI $20.86
  • RGNX $5.04
  • 52 Week High
  • IPI $39.01
  • RGNX $13.48
  • Technical
  • Relative Strength Index (RSI)
  • IPI 41.92
  • RGNX 52.58
  • Support Level
  • IPI $28.33
  • RGNX $8.82
  • Resistance Level
  • IPI $29.87
  • RGNX $10.08
  • Average True Range (ATR)
  • IPI 1.14
  • RGNX 0.55
  • MACD
  • IPI 0.12
  • RGNX -0.03
  • Stochastic Oscillator
  • IPI 14.17
  • RGNX 42.66

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: